DGCR8 and skin basal cell carcinoma: Similarly, D-BCC-sEVs derived from METTL3 or DGCR8-silenced or STM2457 pretreated 231 cells abrogated the transmissions of miR-338-3p by D-BCC-sEVs (Supplementary Fig. 7E–G).